Coronavirus disease 2019 vaccine skin testing and graded challenges in vaccine-hesitant patients
Vaccine hesitancy remains a significant obstacle to vaccine uptake.1 Adverse reactions to coronavirus disease 2019 vaccines (CO19V), although rare,2,3 are a contributing factor. Studies4,5 report that many patients who fulfill the criteria for anaphylaxis can receive the vaccine. However, overcoming this hesitancy continues to be an issue for many who refuse to receive the vaccine.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Ari Heffes-Doon, Nathanael Horne, Chinyere Okpara, Meredith Akerman, Luz Fonacier Tags: Letters Source Type: research
More News: Allergy | Allergy & Immunology | Anaphylactic Shock | Asthma | Coronavirus | Covid Vaccine | COVID-19 | Skin | Vaccines